Start with the entities, then assign the work

List the legal names behind the brand, clinical services, platform, pharmacy, payment collection and marketing. One company may perform several functions. Several companies may share a patient journey. A logo on the checkout page will not tell your team which entity must respond to a privacy request or approve a clinical workflow. This guide is an educational operating framework. Healthcare counsel and clinical leads should validate its application to your structure and jurisdictions.

HHS explains that HIPAA applies to covered entities and business associates, with certain obligations applying directly to business associates. The distinction depends on the entity's activities, not a vendor's general claim of compliance. Record counsel's role assessment alongside each legal entity, rather than labeling the entire brand with one blanket status.

Source context: HHS: Covered Entities and Business Associates

Separate a decision from a task

A platform can display a consent form while the clinical organization owns the required wording and clinical process. An agency can prepare an advertisement while the brand controls publication. A support representative can receive a medication complaint while a clinician or pharmacist handles the substance of the question. Each row needs both the person doing the work and the person authorized to approve it.

State restrictions can reach decisions that founders consider administrative. The Medical Board of California describes limits on unlicensed control over physician judgment and certain management decisions. That is a California example, not a nationwide ownership rule. Use it as a prompt for state-specific counsel review of hiring authority, workload decisions, records and contracts.

Source context: Medical Board of California: Practice Information

Make every handoff produce evidence

Write the deliverable that closes each task. State availability needs a reviewed coverage record. Advertising needs the approved version and supporting material. Access removal needs a completed access log. An incident needs the time discovered, people notified and investigation owner. A calendar invitation or the phrase 'vendor handles it' is weak evidence because neither shows what was done.

Keep the matrix close to the order workflow. Walk one sample journey from advertisement to support. At every boundary ask who receives the next item, what confirms receipt, and what happens if the receiving partner is unavailable. Capture those answers before paid traffic turns a missing handoff into a patient complaint.

Give shared issues a coordinator

A security incident, misleading advertisement or pharmacy interruption can involve several entities at once. Assign an operational coordinator who gathers facts and convenes the appropriate decision makers. The coordinator should not make clinical or legal determinations outside their authority. Specify a backup contact, the approved communication channel and who may stop the affected workflow.

FTC health advertising guidance explains that parties participating in or controlling deceptive marketing can face responsibility. Treat an agency approval as one checkpoint, not a transfer of all accountability. Use the advertising review checklist to connect claims, evidence and publication authority.

Source context: FTC: Health Products Compliance Guidance

Review the matrix whenever the system changes

Reopen affected rows when you add a state, pharmacy, intake question, tracking tool, support vendor or product category. Assign a date for the next review and preserve prior versions. Ask each partner to confirm its rows in writing. Unanswered rows remain launch blockers for that workflow rather than being filled with assumptions.

During a tabletop review, choose a single failure such as a patient asking for records after a vendor outage. Have the assigned owners describe their first actions using the documents they can access. If they cannot find the record, contact or authority, improve the process and repeat that scenario. A completed matrix is useful when it changes behavior under pressure.

Responsibility and evidence matrix

Replace role names with named people and legal entities. Confirm the authority and obligations with counsel and clinical leadership; these are planning prompts, not a legal allocation.

On small screens, scroll the table sideways to view every column.

Responsibility and evidence matrix
ProcessDecision owner to confirmExecution and evidenceEscalation trigger
State launchCounsel and clinical organizationOperations: approved state coverage recordLicense, scope or coverage uncertainty
Health advertisingBrand publication owner with appropriate reviewersMarketing: approved copy and support fileUnsupported claim or changed offer
Data incidentAffected entities' privacy/security and legal leadsCoordinator: incident log and notice assessmentSuspected unauthorized access or disclosure
Clinical supportClinical organizationSupport: secure handoff and receiptClinical question or safety concern
Pharmacy interruptionPharmacy and clinical leads for their functionsOperations: affected-order list and response recordDispensing delay, quality issue or recall
Download this worksheet as CSV

Before you move forward

  • List every legal entity in the patient journey.
  • Confirm each decision owner's authority and backup.
  • Link the evidence required to close each task.
  • Set triggers for pausing an affected workflow.
  • Test one cross-vendor failure and revise missing handoffs.

Sources and scope

Source check: October 10, 2026. Primary sources support the rules and vendor descriptions cited above. Worksheets are original planning tools, not provider commitments or forecasts. Requirements can change; confirm current terms for your program.

  1. HHS: Covered Entities and Business Associates

    Supports role-based HIPAA applicability and direct business-associate obligations. Checked October 10, 2026.

  2. Medical Board of California: Practice Information

    Provides California-specific examples of prohibited unlicensed control, not a national rule. Checked October 10, 2026.

  3. FTC: Health Products Compliance Guidance

    Supports responsibility for participating in or controlling deceptive health marketing. Checked October 10, 2026.